Structure-based design for binding peptides in anti-cancer therapy
Authors:
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Biomaterials
- Vol. 156, 1-15
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of Taiwan (MOST 103-2321-B-182A-003, MOST 104-2321-B-182A-001, MOST 106-3114-B-182A-001)
- CGMH (OMRPG3C0041, OMRPG3C0045)
This publication has 115 references indexed in Scilit:
- Quantifying Water-Mediated Protein–Ligand Interactions in a Glutamate Receptor: A DFT StudyThe Journal of Physical Chemistry B, 2011
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targetingBiochemical Journal, 2011
- Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2010
- Cancer-selective apoptotic effects of extracellular and intracellular Par-4Oncogene, 2010
- Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathwaysOncogene, 2009
- Molecular recognition of parathyroid hormone by its G protein-coupled receptorProceedings of the National Academy of Sciences, 2008
- Flexible ligand docking to multiple receptor conformations: a practical alternativeCurrent Opinion in Structural Biology, 2008
- GRP78 and Raf‐1 cooperatively confer resistance to endoplasmic reticulum stress‐induced apoptosisJournal of Cellular Physiology, 2007
- Mechanistic Studies of a Peptidic GRP78 Ligand for Cancer Cell-Specific Drug DeliveryMolecular Pharmaceutics, 2007
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006